Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
July 30 2024 - 7:30AM
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a
global leader in innovations for active healing, today announced
that it will report financial results for the second quarter of
fiscal year 2024 before the market opens on Tuesday, August 6,
2024. The Company’s management will host a conference call at 8:30
a.m. Eastern Time that same day to discuss the results and provide
a business update.
To participate in the conference call, dial 1-833-636-0497 and
refer to the Bioventus Inc. Conference Call.
A live webcast of the call and accompanying materials will also
be provided on the “Investor Relations” section of the Company's
website at https://ir.bioventus.com/. The webcast will be
archived at the same site and available for replay until August 5,
2025.
About BioventusBioventus delivers clinically
proven, cost-effective products that help people heal quickly and
safely. Its mission is to make a difference by helping patients
resume and enjoy active lives. The Innovations for Active Healing
from Bioventus include offerings for Pain Treatments, Restorative
Therapies and Surgical Solutions. Built on a commitment to high
quality standards, evidence-based medicine and strong ethical
behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.bioventus.com and follow the
Company on LinkedIn and Twitter. Bioventus and the Bioventus logo
are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:Dave
Crawford919-474-6787Dave.Crawford@bioventus.com
Bioventus (NASDAQ:BVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bioventus (NASDAQ:BVS)
Historical Stock Chart
From Sep 2023 to Sep 2024